Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients #MMPMID32255489
Perinel S; Launay M; Botelho-Nevers E; Diconne E; Louf-Durier A; Lachand R; Murgier M; Page D; Vermesch R; Thierry G; Delavenne X
Clin Infect Dis 2020[Nov]; 71 (16): 2227-2229 PMID32255489show ga
Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting in various concentrations. Pharmacokinetic studies are therefore needed to define the optimal dosing regimen.